AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « registry »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
registries < registry < regression  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 36.
[0-20] [0 - 20][0 - 36][20-35][20-40]
Ident.Authors (with country if any)Title
000150 (2012) O. Psenak [Autriche] ; A. Studnicka-Benke [Autriche] ; R. Greil [Autriche]Sicherheit der Immunsuppressiva
000161 (2013) I. Kötter [Allemagne] ; J. C. Henes [Allemagne]Etablierte Medikamente
000178 (2010) G. Dückers [Allemagne] ; T. Niehues [Allemagne]Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still)
000221 (2015) Ester G. Penserga [Philippines] ; Therese Aileen L. Natividad [Philippines] ; Evelyn S. Salido [Philippines]Clinical profile of 266 Filipino patients with rheumatoid arthritis included in the rheumatoid arthritis database and registry (RADAR) of the Philippine General Hospital
000249 (2010) R. E. Fischer-Betz [Allemagne] ; M. Schneider [Allemagne]Biologika in Schwangerschaft und Stillzeit
000306 (2013) Pavel Horák [République tchèque] ; Martina Skácelová [République tchèque] ; Karel Hejduk [République tchèque] ; Andrea Smržová [République tchèque] ; Karel Pavelka [République tchèque]Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry
000375 (2013) G. Horneff ; S. Nimmrich [Allemagne]SAT0463 Incidence of Herpes Zoster Infections in Juvenile Idiopathic Arthritis Patients – Experience of the Biker Registry
000432 (2013) K. Pavelka [République tchèque] ; K. Hejduk [République tchèque] ; H. Mann [République tchèque] ; E. Dokoupilova ; D. Suchy [République tchèque]AB0317 Swollen joints- the only predictor of achieving low disease activity in ra with tocilizumab therapy in czech national registry attra
000540 (2013) N. Asai ; T. Kobayakawa ; K. Saito ; T. Shioura ; Y. Yabe [Japon] ; T. Kojima ; A. Kaneko [Japon] ; N. IshiguroAB0564 Continuation and remission rates of tocilizumab treatment based on improvement in patient global assessment: 2-year study based on the tsurumai biologics communication registry
000560 (2013) L. Harrold ; A. John ; G. Reed ; W. Reiss ; R. Magner ; C. Y. Chung ; K. C. Saunders ; J. M. Kremer ; J. D. Greenberg [États-Unis]AB0551 The use and effectiveness of rituximab in patients with rheumatoid arthritis observational study: Corrona registry
000571 (2013) Y. Kanayama ; T. Kojima ; Y. Hirano ; N. Takahashi ; K. Funahashi ; D. Kato ; H. Matsubara ; Y. Hattori ; Y. Yabe [Japon] ; Y. Oishi ; N. IshiguroAB0585 Radiographic progression of cervical lesions and hands in patients with rheumatoid arthritis receiving tocilizumab treatment from japanese tbc registry
000572 (2013) Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; T. Shioura ; N. Asai ; T. Kobayakawa ; K. Saito [Japon] ; N. IshiguroAB0590 Rates of treatment continuation and remission in 97 patients with high c-reactive protein receiving tocilizumab: 2-year study based on the tsurumai biologics communication registry
000575 (2014) Chi Chiu Mok [République populaire de Chine] ; Ka Yan Chan [République populaire de Chine] ; Ka Lai Lee [République populaire de Chine] ; Lai Shan Tam [République populaire de Chine] ; Ka Wing Lee [République populaire de Chine]Factors associated with withdrawal of the anti‐TNFα biologics in the treatment of rheumatic diseases: data from the Hong Kong Biologics Registry
000605 (2013) P. Ostojic ; N. Damjanov ; A. Dimic ; D. Stefanovic ; M. Lazarevic ; T. Ilic [Serbie] ; S. ZivojinovicAB0566 Improved efficacy of rituximab in rheumatoid arthritis when administered regularly at six-month intervals – data from the serbian registry (NARASS)
000657 (2013) Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. IshiguroAB0591 Analysis of rheumatoid arthritis patients who were treated with abatacept with rapid effectiveness from japanese multicenter registry system of biological therapy
000723 (2013) J. Morel [France] ; M. O. Duzanski [France] ; A. Cantagrel [France] ; B. Combe [France] ; M. Dougados [France] ; R. M. Flipo ; J. E. Gottenberg [France] ; X. Mariette [France] ; O. Vittecoq ; A. Saraux ; T. Schaeverbeke ; T. Bardin [France] ; M. Soubrier ; P. Ravaud [France] ; J. Siblia [France]FRI0245 Prospective follow-up of tocilizumab treatment in 1100 patients with refractory rheumatoid arthritis: tolerance data from the french registry regate (registry –roactemra)
000808 (2013) Y. Saeki ; S. Ohshima ; M. Matsushita ; E. Tanaka-Kudo ; S. Tsuji ; M. Yoshimura ; A. Watanabe ; M. Katayama ; S. Teshigawara ; Y. Katada ; Y. Harada ; A. Yura ; K. Kagawa ; J. Hashimoto ; S. Tohma [Japon]SAT0144 The Causes of Discontinuation of Biologics(Bio)-Use in the Treatment of Rheumatoid Arthritis (RA) Under Practical Circumstances in Japan: from the “Ninja” Registry
000838 (2013) Ž. Rotar [Slovénie] ; M. Tomši [Slovénie]FRI0163 Survival of the second biologic after the first anti-tnf failure in the treatment of rheumatoid arthritis: data from biorx.si registry
000937 (2013) Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. IshiguroAB0339 A retrospective study on rapidness of efficacy in abatacept terapy in patients with rheumatoid arthritis from japanese multicenter registry system
000987 (2013) S. Hirabara [Japon] ; T. Kojima [Japon] ; N. Takahashi [Japon] ; M. Hanabayashi [Japon] ; K. Terabe [Japon] ; Y. Yoshioka [Japon] ; N. Ishiguro [Japon]SAT0134 Clinical Efficacy of Abatacept in Rheumatoid Arthritis Patients with Prior Use of Tocilizumab; Results from Japanese Multicenter Registry System TBCR
000A11 (2013) C. Iking-Konert [Allemagne] ; E. Schmidt ; C. Fiehn ; F. Behrens [Allemagne] ; R. Fischer-Betz ; M. Fleck ; J. Holle ; J. Henes ; A. M. Jacobi ; C. Kneitz ; E. Wittenborn ; H. Schulze-Koops [Allemagne] ; T. Dörner [Allemagne]THU0275 Interim Analysis of the Retrospective German Registry (GRAID2)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "registry" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "registry" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    registry
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021